New drug targets Hard-to-Treat prostate cancer in phase 2 trial

NCT ID NCT06842498

Recruiting now Disease control Sponsor: Kyntra Bio Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 07, 2026 · Updated 22 times

Summary

This study tests a new drug called FG-3246 in 75 people with a type of advanced prostate cancer that no longer responds to standard hormone therapy. The drug is designed to find and attack cancer cells while sparing healthy ones. The goal is to see if it can slow cancer growth and improve outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bioresearch Partner
RECRUITING

Aventura, Florida, 33180, United States
Bioresearch Partner
RECRUITING

Hialeah, Florida, 33013, United States
Carolina Urologic Research Center
RECRUITING

Myrtle Beach, South Carolina, 29572, United States
Duke University Medical Center - Duke Cancer Center
RECRUITING

Durham, North Carolina, 27710, United States
Fred Hutchinson Cancer Center
RECRUITING

Seattle, Washington, 98109, United States
New Mexico Oncology Hematology Consultants, Ltd.
RECRUITING

Albuquerque, New Mexico, 87109, United States
Oncology Consultants
RECRUITING

Houston, Texas, 77030, United States
The University of Arizona Cancer Center - North Campus
RECRUITING

Tucson, Arizona, 85719, United States
UCLA Clark Urology Center
RECRUITING

Los Angeles, California, 90095, United States
UNC Hospitals, The University of North Carolina at Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27514, United States
University Hospitals Cleveland Medical Center
RECRUITING

Cleveland, Ohio, 44106, United States
University of California San Francisco
RECRUITING

San Francisco, California, 94143, United States
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States
University of Virginia Comprehensive Cancer Center
RECRUITING

Charlottesville, Virginia, 22903, United States
Winship Cancer Institute, Emory University
RECRUITING

Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER